Longitude Capital Partners IV, LLC has filed 6 insider transactions across 2 companies since February 2023.
Most recent transaction: a transaction of 1793429 shares of Lexeo Therapeutics, Inc. ($LXEO) on November 07, 2023.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Longitude Capital Partners IV, LLC | TenPercentOwner | C | Common Stock | 1793429 | $0.00 | 1,793,429.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Longitude Capital Partners IV, LLC | TenPercentOwner | C | Common Stock | 319126 | $0.00 | 2,112,555.0000 | 0 | 17.79% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Longitude Capital Partners IV, LLC | TenPercentOwner | P | Common Stock | 454545 | $11.00 | 2,567,100.0000 | 0 | 21.52% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Longitude Capital Partners IV, LLC | TenPercentOwner | C | Series A convertible preferred stock | 18999999 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2023 | Lexeo Therapeutics, Inc. | $LXEO | Longitude Capital Partners IV, LLC | TenPercentOwner | C | Series B convertible preferred stock | 2906148 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2023 | Vera Therapeutics, Inc. | $VERA | Longitude Capital Partners IV, LLC | TenPercentOwner | P | Class A Common Stock | 1714285 | $7.00 | 5,144,212.0000 | 0 | 49.98% | 0.00% |